Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
University of Heidelberg |
---|---|
Information provided by: | University of Heidelberg |
ClinicalTrials.gov Identifier: | NCT00175981 |
Aim of the study is to assess the interaction between sildenafil and fluvoxamine and its effect on the venous response to sodium nitroprusside.
Condition | Intervention | Phase |
---|---|---|
Healthy |
Drug: sildenafil, fluvoxamine |
Phase I |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment |
Official Title: | Pharmacokinetic and Pharmacodynamic Evaluation of the Interaction Between Fluvoxamine and Sildenafil in Healthy Males |
Estimated Enrollment: | 12 |
Study Start Date: | February 2003 |
Estimated Study Completion Date: | November 2004 |
In a randomised, double-blind, placebo-controlled, cross-over study in healthy men we will assess the effect of oral fluvoxamine (50mg qd on day 1-3; 100mg qd on day 4-10) on sildenafil kinetics (single oral 50mg dose on day 11). Sildenafil plasma concentrations will be determined by LC/MS. We will also assess the effect of sildenafil on venodilation induced by a constant dose-rate of the NO-donor sodium nitroprusside (SNP) during preconstriction with phenylephrine (dorsal hand vein compliance technique).
Ages Eligible for Study: | 18 Years to 45 Years |
Genders Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Germany, Baden-Württemberg | |
Dept. of Internal Medicine VI, University of Heidelberg | |
Heidelberg, Baden-Württemberg, Germany, 69120 |
Principal Investigator: | Walter E Haefeli, MD | University of Heidelberg |
Study ID Numbers: | K058 |
Study First Received: | September 9, 2005 |
Last Updated: | September 9, 2005 |
ClinicalTrials.gov Identifier: | NCT00175981 |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Fluvoxamine Sildenafil Healthy Serotonin |
Vasodilator Agents Neurotransmitter Uptake Inhibitors Neurotransmitter Agents Tranquilizing Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Psychotropic Drugs Central Nervous System Depressants Enzyme Inhibitors Cardiovascular Agents |
Serotonin Uptake Inhibitors Pharmacologic Actions Phosphodiesterase Inhibitors Serotonin Agents Therapeutic Uses Anti-Anxiety Agents Antidepressive Agents, Second-Generation Central Nervous System Agents Antidepressive Agents |